BL Pharmtech Corp.

₩1,612As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:065170Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (12.90%)
Div yield —
ROE (103.82%)
Pharmaceutical Preparations
Beta (5Y) 2.45
PE TTM —
TSR TTM 140.96%
Mkt cap ₩44.99B
ROIC (18.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,806
12.01%
29.28%
Sell 4|10|7|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
28.59
28.37
28.57
30.67
8.52%
6.83%
1.03%
6.90%
Revenue₩B
4.174
4.401
4.480
4.605
9.58%
10.61%
10.42%
11.96%
Peers (US$33.17M)
Cap (US$)
PE
33.23M
6.691x
31.33M
11.57x
Capital
TTM
5Y
10Y
Leveragex
0.515
—
—
EBIT/Intx
4.602
1.133
1.133
Own earn%
(14.13)
22.45
16.67
Sh yield%
33.04
40.52
42.79
Owners
Insiders/Inst%
9.88
25.85
Short interest%
5.82
SBC / revenue%
3.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
22–26
$1 testx
0.0
Incr. ROIC%
128